bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 27, 2025
Abstract
Antiretroviral
therapy
(ART)
has
dramatically
improved
the
clinical
prognosis
for
people
with
HIV
and
prevents
transmission.
However,
ART
does
not
cure
infection
because
of
a
persistent,
latent
reservoir
in
long-lived
cells
such
as
central
memory
CD4
+
T
(T
CM
)
cells.
Eliminating
or
preventing
formation
will
require
better
understanding
HIV-1
latency
establishment.
We
others
have
recently
shown
that
host
cell
factors
histone
deacetylases
(HDACs)
are
critical
cellular
allow
entry
into
latency.
Whether
HDACs
interact
specific
viral
to
regulate
establishment,
however,
is
unknown.
To
examine
role
individual
accessory
proteins,
we
constructed
panel
reporter
strains,
each
expressing
single
protein,
examined
them
primary
T-cell
model.
Interestingly,
found
HDAC
inhibitor
(HDACi)
vorinostat
potently
enhances
effect
protein
Vpr
promoting
expression
infected
cells,
suggesting
possesses
cryptic
transcription-promoting
activity
restricted
by
HDACs.
This
was
dependent
on
p300-binding
domain
inhibited
selective
p300
acetyltransferase
inhibitor.
also
resulted
significant
increase
proportion
phenotype.
Furthermore,
observed
were
more
resistant
Vpr-induced
apoptosis/cell
death
than
other
subtypes,
indicating
during
selects
proviruses
Overall,
these
findings
suggest
plays
an
important
shaping
results,
part,
from
HDAC-mediated
restriction
Vpr’s
activity.
Understanding
how
shape
establishment
aid
development
new
latency-targeting
therapies.
Author
Summary
Although
antiretroviral
effective
at
treating
HIV,
remains
elusive.
The
obstacle
presence
latently
which
virus
persists
despite
therapy.
Recent
work
sizable
fraction
this
forms
near
time
initiated,
it
may
be
possible
prevent
some
forming.
prevention
enters
latency,
including
gene
silenced.
therefore
sought
interaction
between
proteins
turning
off
that,
whereas
turns
expression,
block
Second,
leads
relative
type
harbors
virus.
Our
silencing
persistence
certain
types
developing
approaches
targeting
Nature,
Journal Year:
2021,
Volume and Issue:
601(7893), P. 440 - 445
Published: Nov. 18, 2021
Abstract
All
life
forms
defend
their
genome
against
DNA
invasion.
Eukaryotic
cells
recognize
incoming
and
limit
its
transcription
through
repressive
chromatin
modifications.
The
human
silencing
hub
(HUSH)
complex
transcriptionally
represses
long
interspersed
element-1
retrotransposons
(L1s)
retroviruses
histone
H3
lysine
9
trimethylation
(H3K9me3)
1–3
.
How
HUSH
recognizes
initiates
of
these
invading
genetic
elements
is
unknown.
Here
we
show
that
able
to
repress
a
broad
range
long,
intronless
transgenes.
Intron
insertion
into
HUSH-repressed
transgenes
counteracts
repression,
even
in
the
absence
intron
splicing.
binds
transcripts
from
target
locus,
prior
independent
H3K9me3
deposition,
essential
for
both
initiation
propagation
HUSH-mediated
H3K9me3.
Genomic
data
reveal
how
subset
endogenous
genes
generated
retrotransposition
cellular
mRNAs.
Thus
cDNA—the
hallmark
reverse
transcription—provides
versatile
way
distinguish
retroelements
host
enables
protect
‘non-self’
DNA,
despite
there
being
no
previous
exposure
element.
Our
findings
existence
transcription-dependent
genome-surveillance
system
explain
it
provides
immediate
protection
newly
acquired
while
avoiding
inappropriate
repression
genes.
Journal of the American Chemical Society,
Journal Year:
2022,
Volume and Issue:
144(40), P. 18688 - 18699
Published: Sept. 28, 2022
Targeted
protein
degradation
induced
by
heterobifunctional
compounds
and
molecular
glues
presents
an
exciting
avenue
for
chemical
probe
drug
discovery.
To
date,
small-molecule
ligands
have
been
discovered
only
a
limited
number
of
E3
ligases,
which
is
important
limiting
factor
realizing
the
full
potential
targeted
degradation.
We
report
herein
discovery
proteomics
azetidine
acrylamides
that
stereoselectively
site-specifically
react
with
cysteine
(C1113)
in
ligase
substrate
receptor
DCAF1.
demonstrate
acrylamide
DCAF1
can
be
developed
into
electrophilic
proteolysis-targeting
chimeras
(PROTACs)
mediated
human
cells.
show
this
process
stereoselective
does
not
occur
cells
expressing
C1113A
mutant
Mechanistic
studies
indicate
low
fractional
engagement
required
to
support
PROTACs.
These
findings,
taken
together,
how
proteomic
analysis
stereochemically
defined
compound
sets
uncover
ligandable
sites
on
ligases
Nature Communications,
Journal Year:
2020,
Volume and Issue:
11(1)
Published: Oct. 2, 2020
Abstract
The
HUSH
complex
represses
retroviruses,
transposons
and
genes
to
maintain
the
integrity
of
vertebrate
genomes.
regulates
deposition
epigenetic
mark
H3K9me3,
but
how
its
three
core
subunits
—
TASOR,
MPP8
Periphilin
contribute
assembly
targeting
remains
unknown.
Here,
we
define
biochemical
basis
find
that
modular
architecture
resembles
yeast
RNA-induced
transcriptional
silencing
complex.
central
subunit,
associates
with
RNA
processing
components.
TASOR
is
required
for
H3K9me3
over
LINE-1
repeats
repetitive
exons
in
transcribed
genes.
In
context
previous
studies,
this
suggests
an
intermediate
important
activity.
We
dissect
domains
necessary
transgene
repression.
Structure-function
analyses
reveal
bears
a
catalytically-inactive
PARP
domain
targeted
deposition.
conclude
multifunctional
pseudo-PARP
directs
regulation
genomic
targets.
Cell Host & Microbe,
Journal Year:
2021,
Volume and Issue:
29(5), P. 792 - 805.e6
Published: April 2, 2021
Silencing
of
nuclear
DNA
is
an
essential
feature
innate
immune
responses
to
invading
pathogens.
Early
in
infection,
unintegrated
lentiviral
cDNA
accumulates
the
nucleus
yet
remains
poorly
expressed.
In
HIV-1-like
lentiviruses,
Vpr
accessory
protein
enhances
viral
expression,
suggesting
antagonizes
cellular
restriction.
We
previously
showed
how
remodels
host
proteome,
identifying
multiple
targets.
now
screen
these
using
a
targeted
CRISPR-Cas9
library
and
identify
SMC5-SMC6
complex
localization
factor
2
(SLF2)
as
target
responsible
for
silencing
HIV-1.
SLF2
recruits
SMC5/6
depletion
SLF2,
or
complex,
increases
expression.
ATAC-seq
demonstrates
that
Vpr-mediated
chromatin
accessibility
virus,
compacts
silence
gene
This
work
implicates
immunosurveillance
extrachromosomal
defines
its
targeting
by
evolutionarily
conserved
antagonism.
Nature Communications,
Journal Year:
2022,
Volume and Issue:
13(1)
Published: Jan. 10, 2022
Abstract
The
Human
Silencing
Hub
(HUSH)
complex
constituted
of
TASOR,
MPP8
and
Periphilin
recruits
the
histone
methyl-transferase
SETDB1
to
spread
H3K9me3
repressive
marks
across
genes
transgenes
in
an
integration
site-dependent
manner.
deposition
these
leads
heterochromatin
formation
inhibits
gene
expression,
but
underlying
mechanism
is
not
fully
understood.
Here,
we
show
that
TASOR
silencing
or
HIV-2
Vpx
which
induces
degradation,
increases
accumulation
transcripts
derived
from
HIV-1
LTR
promoter
at
a
post-transcriptional
level.
Furthermore,
using
yeast
2-hybrid
screen,
identify
new
partners
involved
RNA
metabolism
including
deadenylase
CCR4-NOT
scaffold
CNOT1.
CNOT1
synergistically
repress
HIV
expression
its
LTR.
Similar
RNA-induced
transcriptional
found
fission
yeast,
interacts
with
exosome
Polymerase
II,
predominantly
under
elongating
state.
Finally,
facilitates
association
degradation
proteins
polymerase
II
detected
centers.
Altogether,
propose
HUSH
operates
levels
proviral
expression.
Trends in Genetics,
Journal Year:
2023,
Volume and Issue:
39(4), P. 251 - 267
Published: Feb. 6, 2023
The
vertebrate
genome
is
under
constant
threat
of
invasion
by
genetic
parasites.
Whether
the
host
can
immediately
recognize
and
respond
to
invading
elements
has
been
unclear.
discovery
human
silencing
hub
(HUSH)
complex,
finding
that
it
provides
immediate
protection
from
products
reverse
transcription,
have
important
implications
for
mammalian
evolution.
In
this
review,
we
summarize
recent
insights
into
HUSH
function
describe
how
cellular
introns
provide
a
novel
means
self–nonself
discrimination,
allowing
transcriptionally
repress
broad
range
intronless
elements.
We
discuss
contributes
evolution,
highlight
studies
reporting
critical
role
in
development
implicating
control
immune
signaling
cancer
progression.
The
HIV-1
Vpr
accessory
protein
induces
ubiquitin/proteasome-dependent
degradation
of
many
cellular
proteins
by
recruiting
them
to
a
cullin4A-DDB1-DCAF1
complex.
In
so
doing,
enhances
gene
expression
and
(G2/M)
cell
cycle
arrest.
However,
the
identities
target
through
which
these
biological
effects
are
exerted
unknown.
We
show
that
chromosome
periphery
protein,
CCDC137/cPERP-B,
is
targeted
for
depletion
Vpr,
in
dependent
manner.
CCDC137
caused
G2/M
cellcycle
arrest,
while
Vpr-resistant
mutants
conferred
resistance
Vpr-induced
also
recapitulated
ability
enhance
expression,
particularly
macrophages.
Our
findings
indicate
promotes
cell-cycle
arrest
CCDC137.